Intravenous Magnesium in Arterial Disease

[Guest guest]

Intravenous Magnesium in Arterial Disease

S. E. Browne

http://mgwater.com/browne02.shtml

 

The coronary collateral circulation has immense potential for the

prevention and treatment of coronary heart disease as has collateral

circulation in other forms of arterial disease. It is idle to

speculate about the state of the coronary collateral circulation in

for example Stone Age Man but tragically in modern man it is usually

closed and inactive and of no assistance in myocardial infarction or

angina. Haddy has shown that the higher the concentration of

magnesium infused into dog's arteries the greater the resulting

vasodilatation.

 

Rapid intravenous bolus doses of 8 to 12 mmols of magnesium have

been shown to instantaneously and effectively dilate the coronary

collateral circulation proving a dramatically effective treatment of

acute myocardial infarction, angina and congestive heart failure.

For example a man of 44 had a severe myocardial infarction with

subsequent crippling angina and a ventricular aneurysm. After 6

rapid intravenous injections of 8 mmols of magnesium he was

completely free from angina and enjoyed life for a further 17 years.

His coronary arteriogram showed a completely blocked left anterior

descending artery but the distal portion was well filled by

collateral circulation from the right coronary artery. Out of 126

patients with angina 116 patients had either complete or marked

relief of pain after intravenous magnesium. Out of 59 patients with

acute myocardial infarction 26 had immediate relief of pain after 8

mmols of magnesium had been given and all 59 recovered without any

evidence of arrhythmias. Of 30 patients with cardiac congestive

failure 24 were markedly improved.

 

Opening collateral circulation in the brain is also effective. In

non-haemorrhagic cerebral arterial disease intravenous magnesium has

secured complete relief of paralysis in 18 out of 35 patients. It

has also proved effective in claudication, gangrene, chronic leg

ulceration, chilblains, and early renal disease.

 

Its preventive use in early middle age would improve life expectancy

considerably, as it would minimise the impact of subsequent arterial

disease or prevent tissue damage completely.

 

Ref. Browne SE. The case for intravenous magnesium treatment of

arterial disease in general practice. Review of 34 years of

experience. Journal of Nutritional Medicine (1994) 4, 169-177.

 

 

---

-----------

 

This page was first uploaded to The Magnesium Web Site on July 22,

2000